Overview
- Legal name
- BIOLOGICS, INC.
- Also known as
- BIOLOGICS BY MCKESSON
- Registered location
- CARY, NC, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Apr 28, 2026
Read company summary
BIOLOGICS, INC. is associated with UEI GVRYEDLFU6J3 and CAGE 6LEB9 in public federal records. AcornBids currently links 17 prime awards totaling $685.3K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Justice. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists CARY, NC, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 23, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BIOLOGICS, INC.
- Doing business as
- BIOLOGICS BY MCKESSON
- UEI
- GVRYEDLFU6J3
- CAGE
- 6LEB9
- Registered address
- 11800 WESTON PKWY, CARY, NC, 27513, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Oct 8, 2025
- Initial registration
- Nov 18, 2011
- Entity start
- Jan 13, 1994
- SAM updated
- Jan 9, 2026
- Registration expires
- Oct 8, 2026
- Fiscal year end
- Mar 31
- Place of incorporation
- NC, USA
Research brief
Source facts
- Loaded prime-award records link 17 awards and $685,280 in reported obligations to this legal entity. Source
- Recorded awards include Pharmaceutical Preparation Manufacturing (NAICS 325412); this classification is not proof of every company capability. Source
- An example award describes: SPECIALTY MEDICATION DOS: 4/3- 9/30/2026 Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 17 of 17 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $305.5K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $379.7K |
| Change | $-74.2K |
| Growth | -19.5% |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Justice | $549.5K | 13 |
| Department of Veterans Affairs | $135.8K | 4 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| FMC BUTNER | $286.3K | 1 |
| FMC CARSWELL | $263.2K | 12 |
| 261-NETWORK CONTRACT OFFICE 21 (36C261) | $125.8K | 3 |
| NETWORK CONTRACT OFFICE 19 (36C259) | $10.0K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $685.3K | 17 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $685.3K | 17 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $685.3K | 17 |
States
| Category | Period obligations | Awards |
|---|---|---|
| NC | $685.3K | 17 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $685.3K | 17 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 15B10626P00000273SPECIALTY MEDICATION DOS: 4/3- 9/30/2026 | Department of Justice | $286.3K | Apr 3, 2026 | Sep 30, 2026 |
| 36C25925P1069EMERGENCY! PHARMACY BUY, LENALIDOMIDE | Department of Veterans Affairs | $10.0K | Aug 21, 2025 | Sep 30, 2025 |
| 36C26126P0068LENALIDOMIDE 15MG, 10MG NDCS: 76282-0699-47, 76282-0698-48 | Department of Veterans Affairs | $29.6K | Oct 14, 2025 | Dec 14, 2025 |
| 36C26125P1616LENALIDOMIDE 5MG NDC: 76282-0697-48 | Department of Veterans Affairs | $18.7K | Sep 23, 2025 | Nov 23, 2025 |
| 36C26125P1544LENALIDOMIDE | Department of Veterans Affairs | $77.5K | Sep 9, 2025 | Nov 9, 2025 |
| 15B50525P00000138CANCER DRUG BIOLOGICS (MCKESSON) SEPT ORDER FY25 | Department of Justice | $22.1K | Sep 12, 2025 | Sep 12, 2025 |
| 15B50525P00000139CANCER DRUG BIOLOGICS (MCKESSON) JULY ORDER FY25 | Department of Justice | $22.1K | Jul 31, 2025 | Jul 31, 2025 |
| 15B50525P00000140CANCER DRUG BIOLOGICS (MCKESSON) AUGUST ORDER FY25 | Department of Justice | $22.1K | Aug 31, 2025 | Aug 31, 2025 |
| 15B50525P00000113CANCER DRUG BIOLOGICS (MCKESSON) JUNE ORDER FY25 | Department of Justice | $22.1K | Jun 25, 2025 | Jun 25, 2025 |
| 15B50525P00000089CANCER DRUG BIOLOGICS (MCKESSON) MAY ORDER FY25 | Department of Justice | $22.1K | May 1, 2025 | May 31, 2025 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jan 9, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Nov 18, 2011 |
| Entity start | Jan 13, 1994 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 424210 — Drugs and Druggists' Sundries Merchant Wholesalers | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| MICHAEL D'ERCOLE | Government business | Contact method not published | SAM registration | Not available |
| ALLISON JOHN | Alternate government business | Contact method not published | SAM registration | Not available |
| MICHAEL D'ERCOLE | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 424210 — Drugs and Druggists' Sundries Merchant Wholesalers
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Reported subsidiary tree
Ownership follows reported parent UEIs.
- MCKESSON CORPORATIONUEI S1RUKWWRYFL6
- BIOLOGICS, INC.UEI GVRYEDLFU6J3
- CHANGE HEALTHCARE OPERATIONS, LLCUEI C7DYEBLK3PE1
- MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLCUEI XFHRZSRBK6Q1
- MCKESSON PLASMA AND BIOLOGICS LLCUEI M986PPZNJ8M8
Corporate family
Reported ownership links. Award and funding explorers can include this family.
| Legal entity | Reported parent UEI | Source loaded |
|---|---|---|
| MCKESSON CORPORATION | S1RUKWWRYFL6 | Sep 26, 2026 |
| BIOLOGICS, INC. | S1RUKWWRYFL6 | Sep 26, 2026 |
| CHANGE HEALTHCARE OPERATIONS, LLC | S1RUKWWRYFL6 | Sep 26, 2026 |
| MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLC | S1RUKWWRYFL6 | Oct 17, 2026 |
| MCKESSON PLASMA AND BIOLOGICS LLC | S1RUKWWRYFL6 | Sep 26, 2026 |
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit